Contribution of membrane transporters to chemotherapy‐induced cardiotoxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Contribution of membrane transporters to chemotherapy‐induced cardiotoxicity

Published:2021-07-21 Issue:S1 Volume:130 Page:36-47
ISSN:1742-7835
Container-title:Basic & Clinical Pharmacology & Toxicology
language:en
Short-container-title:Basic Clin Pharma Tox

Author:

Uddin Muhammad Erfan¹^ORCID,Moseley Angie¹,Hu Shuiying¹^ORCID,Sparreboom Alex¹^ORCID

Affiliation:

1. Division of Pharmaceutics and Pharmacology, College of Pharmacy The Ohio State University Columbus Ohio USA

Funder

Institut National de la Santé et de la Recherche Médicale

American Heart Association

Publisher

Wiley

Subject

Pharmacology,Toxicology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcpt.13635

Reference68 articles.

1. Phase II and Phase III attrition rates 2011–2012

2. The SIDER database of drugs and side effects

3. A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors

4. Recent Advances in Pharmacological and Non-Pharmacological Strategies of Cardioprotection

5. Cardioprotective Effects and Duration of Beta Blocker Therapy in Anthracycline-Treated Patients: A Systematic Review and Meta-analysis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition;Biochemical Pharmacology;2024-03

2. Membrane transporters in drug development and as determinants of precision medicine;Nature Reviews Drug Discovery;2024-01-24

3. Molecular genetic markers of chemotherapy-induced cardiotoxicity in patients with oncohematological diseases (review);Advances in Molecular Oncology;2023-12-14

4. Doxorubicin Interaction with Lipid Monolayers Leads to Decreased Membrane Stiffness when Experiencing Compression–Expansion Dynamics;Langmuir;2023-06-15

5. Will nanomedicine become a good solution for the cardiotoxicity of chemotherapy drugs?;Frontiers in Pharmacology;2023-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3